title: Radiofrequency ablation for pre-excitation syndromes and AV nodal re-entrant tachycardia.
abstract: Radiofrequency catheter ablation for supraventricular tachycardia was introduced in 1990. Since then it has become the standard for definitive treatment of pre-excitation syndromes and atrioventricular re-entrant tachycardia. In general, catheter ablation of supraventricular tachycardia results in improved outcomes compared to pharmacologic treatment. Over 95% of patients will be successfully treated with catheter ablation with less than a 5% chance of recurrence and <1% risk of major complications.
authors.affiliation: Cardiology Department, John Hunter Hospital, Newcastle 2300, Australia. Cardio@hunterheart.com.au
authors.forename: James
authors.initials: J
authors.lastname: Leitch
authors.forename: Malcolm
authors.initials: M
authors.lastname: Barlow
mesh_terms: D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D011226:Pre-Excitation Syndromes / Q000628:therapy*; D012008:Recurrence; D012307:Risk Factors; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000628:therapy*